AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

被引：0
|
作者：
HQ Nguyen
F Okuku
F Ssewankambo
AS Magaret
C Johnston
A Wald
A Kambugu
L Corey
J Orem
C Casper
机构：
[1] University of Washington,Department of Epidemiology
[2] University of Washington,Department of Laboratory Medicine
[3] University of Washington,Deparment of Medicine
[4] Program in Biostatistics,undefined
[5] Fred Hutchinson Cancer Research Center,undefined
[6] Program in Vaccine and Infectious Disease Institute,undefined
[7] Fred Hutchinson Cancer Research Center,undefined
[8] Uganda Cancer Institute,undefined
[9] Infectious Disease Institute,undefined
来源：
Infectious Agents and Cancer | / 4卷 / Suppl 2期
关键词：
Lamivudine; Efavirenz; Nevirapine; Stavudine; Karnofsky Score;
D O I：
10.1186/1750-9378-4-S2-O5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [21] The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment
    Sinha, Sanjeev
    Dhooria, Sahajal
    Kumar, Sanjiv
    Shah, Nipam
    Velpandian, T.
    Ravi, A. K.
    Kumar, Narendra
    Ahmad, Hafeez
    Bhargwa, Akshat
    Chug, Karan
    Bumma, Naresh
    Chandrashekhar, Rahul
    Ekka, Meera
    Sreenivas, Vishnu
    Sharma, Surendra K.
    Samantaray, J. C.
    Mitsuyasu, Ronald
    AIDS RESEARCH AND THERAPY, 2011, 8
  • [22] Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV
    Mahale, Prarthana R.
    Patel, Brijalkumar S.
    Kasmani, Navsin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [23] Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study)
    Pulido, F
    Arribas, JR
    Miró, JM
    Costa, MA
    Gonález, J
    Rubio, R
    Peña, JM
    Torralba, M
    Lonca, M
    Lorenzo, A
    Cepeda, C
    Vázquez, JJ
    Gatell, JM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (04) : 343 - 350
  • [24] Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy
    Rahman, Anita P.
    Eaton, Susan A.
    Nguyen, Sean T.
    Bain, Amy M.
    Payne, Kenna D.
    Bedimo, Roger
    Busti, Anthony J.
    PHARMACOTHERAPY, 2008, 28 (07): : 913 - 919
  • [25] Impact of baseline CD4+ T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study
    Liu Zheng-yin
    Guo Fu-ping
    Han Yang
    Qiu Zhi-feng
    Zuo Ling-yan
    Li Yan-ling
    Li Tai-sheng
    CHINESE MEDICAL JOURNAL, 2009, 122 (20) : 2497 - 2502
  • [26] Association of Single-Nucleotide Polymorphism 3 and c.553G>T of APOA5 with Hypertriglyceridemia after Treatment with Highly Active Antiretroviral Therapy Containing Protease Inhibitors in HIV-Infected Individuals in Taiwan
    Chang, Sui-Yuan
    Ko, Wei-Shin
    Kao, Jau-Tsuen
    Chang, Lan-Yang
    Sun, Hsin-Yun
    Chen, Mao-Yuan
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Chang, Shu-Fang
    Liu, Wen-Chun
    Wu, Cheng-Hsin
    Hsu, Hui-Jen
    Kao, Chuan-Liang
    Lee, Chun-Nan
    Hung, Chien-Ching
    Chang, Shan-Chwen
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (06) : 832 - 835
  • [27] Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy
    van Leth, F
    Wit, FWNM
    Reiss, P
    Schattenkerk, JKME
    van der Ende, ME
    Schneider, MME
    Mulder, JW
    Frissen, PHJ
    deWolf, F
    Lange, JMA
    HIV MEDICINE, 2004, 5 (02) : 74 - 81
123